Edoxaban and the Issue of Drug-Drug Interactions: From Pharmacology to Clinical Practice

Drugs11.50
Volume: 80, Issue: 11, Pages: 1065 - 1083
Published: Jun 5, 2020
Abstract
Edoxaban, a direct factor Xa inhibitor, is the latest of the non-vitamin K antagonist oral anticoagulants (NOACs). Despite being marketed later than other NOACs, its use is now spreading in current clinical practice, being indicated for both thromboprophylaxis in patients with non-valvular atrial fibrillation (NVAF) and for the treatment and prevention of venous thromboembolism (VTE). In patients with multiple conditions, the contemporary...
Paper Details
Title
Edoxaban and the Issue of Drug-Drug Interactions: From Pharmacology to Clinical Practice
Published Date
Jun 5, 2020
Journal
Volume
80
Issue
11
Pages
1065 - 1083
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.